Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results

Go back to Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results

Infinity Pharma (INFI) Tops Q2 EPS by 8c

August 7, 2018 4:58 PM EDT

Infinity Pharma (NASDAQ: INFI) reported Q2 EPS of ($0.12), $0.08 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

... More